Professor Silviu Itescu received the Key Innovator Award, for his leadership and ingenuity in translational science and clinical medicine with adult stem cell therapy. He has established an outstanding reputation as an active faculty member of Melbourne and Monash universities in Australia and as a physician scientist in the fields of stem cell biology, autoimmune diseases, organ transplantation and heart failure. As Mesoblast’s Chief Executive Officer, the company has grown to become the world’s largest regenerative medicine company and is in late-staged development of biotherapeutics based on its broad, proprietary adult mesenchymal precursor cell technology platform for a diverse range of intransigent diseases.
The Vatican
APRIL 28-30, 2016
